Advanced search
Publication Cover
Leukemia & Lymphoma Volume 47, 2006 - Issue 6
Submit an article Journal homepage
58
Views
5
CrossRef citations to date
0
Altmetric
Letter to the Editor

Polyostotic primary bone lymphoma with progression limited in the skeleton: Identical clonal origin of the initial and progressed tumors and a late relapse by VDJ rearrangement analysis

Sheng-Tsung Chang Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan
,
Shih-Sung Chuang Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan; Department of Pathology, Taipei Medical University, Taipei, TaiwanCorrespondence[email protected]
, MD &
Yin-Hsuan Wang Center for Measurement Standards, Industrial Technology Research Institute, Hsinchu, Taiwan
Pages 1144-1148 | Accepted 28 Dec 2005, Published online: 01 Jul 2009

References

  • Desai S, Jambhekar N A, Soman C S, Advani S H. Primary lymphoma of bone: a clinicopathologic study of 25 cases reported over 10 years. J Surg Oncol 1991; 46: 265–269
  • Parker F, Jackson H. Primary reticulum cell sarcoma of bone. Surg Gynecol & Obstet 1939; 68: 45–53
  • Unni K K, Hogendoorn P CW. Malignant lymphoma. World Health Organization classification of tumors: Pathology and genetics of tumors of soft tissue and bone, C DM Fletcher, K K Unni, F Mertens. IARC Press, Lyon 2000; 306–308
  • Hsieh P P, Tseng H H, Chang S T, Fu T Y, Chuang S S. Primary non-Hodgkin's lymphoma of bone—a rare disorder with high frequency of T-cell phenotype in southern Taiwan. Leuk Lymphoma 2006; 47: 65–70
  • Nishiuchi R, Yoshino T, Teramoto N, Sakuma I, Hayashi K, Nakamura S, et al. Clonal analysis by polymerase chain reaction of B-cell lymphoma with late relapse: a report of five cases. Cancer 1996; 77: 757–762
  • Libra M, De Re V, Gasparotto D, Gloghini A, Marzotto A, Milan I, et al. Differentiation between non-Hodgkin's lymphoma recurrence and second primary lymphoma by VDJ rearrangement analysis. Brit J Haematol 2002; 118: 809–812
  • Shioyama Y, Nakamura K, Kunitake N, Kimura M, Terashima H, Masuda K. Relapsed non-Hodgkin's lymphoma: detection and treatment. Rad Med 2000; 18: 369–375
  • Libra M, De Re V, Gloghini A, Navolanic P M, Carbone A, Boiocchi M. Second primary lymphoma or recurrence: a dilemma solved by VDJ rearrangement analysis. Leukemia & Lymphoma 2004; 45: 1539–1543
  • Chuang S S, Lin C N, Shen F C, Liao P J, Liao Y L, Chang J H, et al. Detecting clonal rearrangement in non-Hodgkin's lymphomas in Taiwan by polymerase chain reaction. Leukemia & Lymphoma 2003; 44: 117–121
  • Aiello A, Du M Q, Diss T C, Peng H Z, Pezzella F, Papini D, et al. Simultaneous phenotypically distinct but clonally identical mucosa-associated lymphoid tissue and follicular lymphoma in a patient with Sjögren's syndrome. Blood 1999; 94: 2247–2251
  • Tang Z, Jing W, Lindeman N, Harris N L, Ferry J A. One patient, two lymphoma: simultaneous primary gastric marginal zone lymphoma and primary duodenal follicular lymphoma. Archiv Pathol Lab Med 2004; 128: 1035–1038
  • Matolcsy A, Schattner E J, Knowles D M, Casali P. Clonal evolution of B cells in transformation from low- to high-grade lymphoma. Eur J Immunol 1999; 29: 1253–1264
  • Kuppers R, Klein U, Hansmann M L, Rajewsky K. Cellular origin of humen B-cell lymphomas. New Eng J Med 1999; 341: 1520–1529
  • Alizadeh A A, Eisen M B, Davis R E, Ma C, Lossos I S, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503–511
  • Chang C C, McClintock S, Cleveland R P, Trzpuc T, Vesole D H, Logan B, et al. Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma. Am J Surg Pathol 2004; 28: 464–470
  • de Leval L, Braaten K M, Ancukiewicz M, Kiggundu E, Delaney T, Mankin H J, et al. Diffuse large B-cell lymphoma of bone: an analysis of differentiation-associated antigens with clinical correlation. Am J Surg Pathol 2003; 27: 1269–1277
  • Ohshima K, Kawasaki C, Muta H, Muta K, Deyev V, Haraoka S, et al. CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosis. Histopathol 2001; 39: 156–162
  • Uherova P, Ross C W, Schnitzer B, Singleton T P, Finn W G. The clinical significance of CD10 antigen expressing in diffuse large B-cell lymphomas. Am J Clin Pathol 2001; 115: 582–588
  • Xu Y, McKenna R W, Molberg K H, Kroft S H. Clinicopathological analysis of CD10+ and CD10− diffuse large B-cell lymphoma: identification of a high-risk subset with coexpression of CD10 and bcl-2. Am J Clin Pathol 2001; 116: 183–190
  • Fabiani B, Delmer A, Lepage E, Guettier C, Petrella T, Briere J, et al. CD10 expression in diffuse large B-cell lymphomas does not influence survival. Virchows Archives 2004; 445: 545–551
  • Huebner-Chan D, Fernandes B, Yang G, Lim M S. An immunophenotypic and molecular study of primary large B-cell lymphoma of bone. Mod Pathol 2001; 14: 1000–1007

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.